ArticleACS omega2021

MiR-199 Reverses the Resistance to Gemcitabine in Pancreatic Cancer by Suppressing Stemness through Regulating the Epithelial-Mesenchymal Transition.

Weitian Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.